A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

NCT03096223 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Dermatitis, Atopic

Interventions

DRUG: KHK4083

Sponsor

Kyowa Kirin Co., Ltd.